This has been a big year for Omron Healthcare Inc. In January, the maker of blood pressure monitoring systems launched its HeartGuide smartwatch, which measures blood pressure through the wrist. In May, it started selling the first US Food and Drug Administration-cleared at-home blood pressure monitor with EKG capability, called Complete, on the company website as well as in major online retail stores such Amazon and BestBuy.
Innovator Spotlight: Innovation Through Partnerships Is In Omron Healthcare's Blood
This year, Omron Healthcare launched its new HeartGuide smartwatch and the first FDA-cleared blood pressure monitor with EKG capability. Medtech Insight sat down with Omron's CEO Ranndy Kellogg to learn about upcoming plans.
![Heartbeat and Heart rate line concept on white background. Vector illustration. - Vector](https://insights.citeline.com/resizer/v2/ZLPMRVXT3JIWRGLVIRX6KQOWLM.jpg?smart=true&auth=1f76a6ee0374a8926a34e9f57e945cb393982855639046ea3f56865561119fb2&width=700&height=394)
More from Digital Technologies
France-based Germitec aims to double its yearly revenue by expanding its UV-C disinfection technology for endocavitary ultrasound probes into the US market.
PathAI, a Boston-based AI-pathology startup backed by $355m, partners with Brazil’s largest integrated healthcare network to support diagnosis and treatment of cancer patients using its AISight image management system.
Volta Medical’s TAILORED-AF clinical trial demonstrates that AI can achieve "superior efficacy" in interventional cardiology. The study examined the use of AI-driven Volta AF-Xplorer in addition to pulmonary vein isolation in treating patient with persistent atrial fibrillation.
Precision medicine startup LinusBio launches its breakthrough diagnostic aid across 44 US states. The laboratory test aims to support earlier diagnosis of autism spectrum disorder and can be ordered by health care providers.
More from Medtech Insight
Volta Medical’s TAILORED-AF clinical trial demonstrates that AI can achieve "superior efficacy" in interventional cardiology. The study examined the use of AI-driven Volta AF-Xplorer in addition to pulmonary vein isolation in treating patient with persistent atrial fibrillation.
A federal judge granted Doctors for America’s motion for a temporary restraining order directing the FDA and CDC to restore information removed from the agencies’ websites to comply with a presidential executive order targeting “gender ideology extremism.”
For the fourth time in as many years the FDA has issued a communication concerning a key accessory from Olympus used in several types of urological procedures. This time, however, the agency has added a class I recall confirmation to its original early alert on the device issued in December 2024. A device safety specialist provided Medtech Insight with a deeper understanding of the problem as well as overall scope safety.